Cholinergic	cholinergic	S_chemicals	O
toxicity	toxicity	O	O
resulting	resulting	O	O
from	from	O	O
ocular	ocular	O	O
instillation	instillation	O	O
of	of	O	O
echothiophate	echothiophate	B_chemicals	O
iodide	iodide	S_chemicals	O
eye	eye	B_chemicals	O
drops	drops	I_chemicals	O
.	.	O	O

A	a	O	O
patient	patient	O	O
developed	developed	O	O
a	a	O	O
severe	severe	O	O
cholinergic	cholinergic	S_chemicals	O
syndrome	syndrome	O	S_disease
from	from	O	O
the	the	O	O
use	use	O	O
of	of	O	O
echothiophate	echothiophate	B_chemicals	O
iodide	iodide	S_chemicals	O
ophthalmic	ophthalmic	O	O
drops	drops	O	O
,	,	O	O
presented	presented	O	O
with	with	O	O
profound	profound	O	O
muscle	muscle	O	B_disease
weakness	weakness	O	I_disease
and	and	O	O
was	was	O	O
initially	initially	O	O
given	given	O	O
the	the	O	O
diagnosis	diagnosis	O	O
of	of	O	O
myasthenia	myasthenia	O	B_disease
gravis	gravis	O	I_disease
.	.	O	O

Red	red	O	O
blood	blood	O	O
cell	cell	O	O
and	and	O	O
serum	serum	O	O
cholinesterase	cholinesterase	S_chemicals	O
levels	levels	O	O
were	were	O	O
severely	severely	O	O
depressed	depressed	O	O
and	and	O	O
symptoms	symptoms	O	O
resolved	resolved	O	O
spontaneously	spontaneously	O	O
following	following	O	O
discontinuation	discontinuation	O	O
of	of	O	O
the	the	O	O
eye	eye	B_chemicals	O
drops	drops	I_chemicals	O
.	.	O	O

